News
The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...
CHIKV can trigger long-term joint pain that mimics autoimmune diseases like rheumatoid arthritis, potentially due to ...
The EMA now advises against using the drug for people aged over 65 after 17 serious adverse effects were recorded in this age ...
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
The FDA and CDC are recommending a pause on the use of Ixchiq (chikungunya vaccine, live) in patients 60 years and older during an ongoing safety investigation.
The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...
Mosquitoes can tranmist dengue virus, which has already caused local cases in Florida in 2025... | Clinical And Molecular Dx ...
Older adults are being warned against receiving the chikungunya vaccine before traveling. The Ixchiq vaccination, developed by Valneva to prevent the mosquito-borne chikungunya virus, was approved ...
FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including ...
Find him on Twitter @GabeWhisnant. The U.S. government is advising travelers aged 60 and older to hold off on receiving the chikungunya vaccine as federal health agencies investigate potential ...
A new study published Thursday warns that tiger mosquitoes are increasingly spreading to Europe because of climate change, ...
The U.S. Centers for Disease Control and Prevention accepted its advisory panel's recommendations on vaccines for chikungunya ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results